UK markets closed

Marinus Pharmaceuticals, Inc. (MRNS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.3650+0.0250 (+1.87%)
As of 02:23PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
28,288
30,989
25,478
15,345
1,718
Cost of revenue
2,484
1,934
340
1,478
0
Gross profit
25,804
29,055
25,138
13,867
1,718
Operating expenses
Research development
95,573
99,388
79,912
73,520
51,106
Selling general and administrative
64,574
61,152
56,845
37,278
18,549
Total operating expenses
160,147
160,540
137,926
110,798
69,655
Operating income or loss
-134,343
-131,485
-112,788
-96,931
-67,937
Interest expense
17,094
16,895
10,672
2,582
0
Total other income/expenses net
-2,677
-2,676
104,679
657
-37
Income before tax
-146,882
-142,943
-16,427
-98,776
-67,475
Income tax expense
-
-1,538
3,389
0
-
Income from continuing operations
-145,344
-141,405
-19,816
-98,776
-67,475
Net income
-145,344
-141,405
-19,816
-98,776
-67,475
Net income available to common shareholders
-145,344
-141,405
-19,816
-98,776
-76,355
Basic EPS
-2.78
-2.63
-0.51
-2.69
-2.80
Diluted EPS
-2.78
-2.63
-0.51
-2.69
-2.80
Basic average shares
50,826
53,747
39,073
36,697
27,270
Diluted average shares
50,826
53,747
39,073
36,697
27,270